Intervention not reported
Disability measured on CHAQ (0 to 3; 0 = no disability) Postintervention: first assessment after end of treatment; no later than 3 months · children and adolescents aged 4 years to 18 years, with chronic musculoskeletal pain
1 finding from 1 review
Intervention not reported
Quality of life measured on multiple scales (0 to 100; higher score = better quality of life) Postintervention: first assessment after end of treatment; no later than 3 months · children and adolescents aged 4 years to 18 years, with chronic musculoskeletal pain
1 finding from 1 review
Intervention not reported
Outcomes, Time point of assessment · relatives, patients, and healthcare professionals during resucitation
The review found no eligible studies for this question.
1 finding from 1 review
Mobility · people with transtibial amputation due to peripheral arterial disease or diabetes
1 finding from 1 review
Mobility · people with transtibial amputation due to peripheral arterial disease or diabetes
1 finding from 1 review
no estimate extracted
1 study · 8 participants
Very low
Global assessment of efficacy ≥ 50% improvement in pain Medium‐term · adults with low back pain
1 finding from 1 review
Stakeholders' assessment of review quality (final score) Assessed by 2 editors independently using the RQI from 1 to 5 (average of the 2 ratings), higher scores indicate higher quality. · peer reviewers
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Stakeholders' assessment of review quality (change score) Assessed using either:A) a 5‐point scale, change scores range from −4 to 4 (3 studies);B) a 5‐point scale, expressed by "slope of quality score change"(1 study); orC) the MQAI, from −144 to... · peer reviewers
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Global assessment of treatment success · acutely hospitalised older medical patients
1 finding from 1 review
Global assessment of treatment success · acutely hospitalised older medical patients
1 finding from 1 review
Global assessment of treatment success · acutely hospitalised older medical patients
1 finding from 1 review
Global assessment of treatment success · acutely hospitalised medical patients
1 finding from 1 review
Laxation response: patient assessment of change in bowel status at the end of trial · people with cancer and receiving palliative care with opioid‐induced bowel dysfunction
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Laxation response: patient assessment of change in bowel status at the end of trial · people with cancer irrespective of whether they were receiving palliative care opioid‐induced bowel dysfunction
1 finding from 1 review
Laxation response: patient assessment of change in bowel status at the end of trial · people receiving palliative care irrespective of whether they had cancer with opioid‐induced bowel dysfunction
Methylnaltrexone may leads to higher laxation response: patient assessment of change in bowel statusgat… compared with placebo (low certainty).
1 finding from 1 review
Laxation response: patient assessment of change in bowel status at the end of trial · people with cancer irrespective of whether receiving palliative care and with opioid‐induced bowel dysfunction
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Laxation response: patient assessment of change in bowel status at the end of trial · people receiving palliative care irrespective of whether they had cancer with opioid‐induced bowel dysfunction
Methylnaltrexone lower dose showed no clear difference in laxation response: patient assessment of change in bowel statusgat… compared with higher dose (low certainty).
1 finding from 1 review
Laxation response: patient assessment of change in bowel status at the end of trial · people with cancer irrespective of whether receiving palliative care and with opioid‐induced bowel dysfunction
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Deatha Timing of outcome assessment: 12 months · community‐dwelling adults with a diagnosis of borderline personality disorder
Joint crisis plan plus treatment as usual showed no clear difference in deatha Timing of outcome assessment: 6 months compared with treatment (low certainty).
1 finding from 1 review
Suicidality: mean number of suicide attempts over the preceding 2 weeks Timing of outcome assessment: 12 months · adults meeting 3 or more diagnostic criteria for borderline personality disorder
1 finding from 1 review